← Back to Search

EUS + Liver Biopsy for Liver Disease

N/A
Waitlist Available
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Study Summary

This trial will compare two methods for liver biopsy and measuring portal pressure.

Eligible Conditions
  • Portal Hypertension
  • Chronic Liver Disease
  • Liver Cirrhosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Compare the proportion of adequate Liver Biopsy specimens with reliable portal pressure gradient obtained by TJ or EUS
Secondary outcome measures
Adverse events
Biopsy
PPG-related outcomes
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Transjugular approachExperimental Treatment1 Intervention
Transjugular hepatic venous pressure gradient measurement with liver biopsy (HVPG-LB).
Group II: Endoscopic ultrasound approachExperimental Treatment1 Intervention
Endoscopic ultrasound portal pressure gradient measurement with liver biopsy (EUS-PPG-LB)

Find a Location

Who is running the clinical trial?

McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
442 Previous Clinical Trials
159,116 Total Patients Enrolled

Media Library

Endoscopic ultrasound portal pressure gradient measurement with liver biopsy Clinical Trial Eligibility Overview. Trial Name: NCT05118308 — N/A
Portal Hypertension Research Study Groups: Endoscopic ultrasound approach, Transjugular approach
Portal Hypertension Clinical Trial 2023: Endoscopic ultrasound portal pressure gradient measurement with liver biopsy Highlights & Side Effects. Trial Name: NCT05118308 — N/A
Endoscopic ultrasound portal pressure gradient measurement with liver biopsy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05118308 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies remaining for this clinical experiment?

"Per the clinicaltrials.gov website, this research endeavour is actively recruiting subjects. It was initially posted on November 4th of 2021 and has since been kept up-to-date through December 5th of last year."

Answered by AI

How many persons are eligible to participate in this research?

"Affirmative. The clinicaltrials.gov page suggests that this medical investigation, which was first posted on November 4th 2021, is still open to applicants. 58 volunteers are required at 1 trial centre."

Answered by AI

Are people aged 35 or younger allowed to join this research project?

"This trial has set the age range for participation between 18 and 100, in keeping with its inclusion requirements."

Answered by AI

Am I able to partake in this medical research?

"This clinical trial requires 58 participants that are 18 years of age or older and have been diagnosed with portal hypertension. A key requirement is a prior evaluation for chronic liver disease or portal hypertension."

Answered by AI

Who else is applying?

What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
EUS vs TJ for Liver Biopsy and Portal Pressure Gradient Measurement
Amine Benmassaoud 2021. "EUS vs TJ for Liver Biopsy and Portal Pressure Gradient Measurement". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05118308.
~17 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top